Medicaid Drug Rebate Program Newly Reported Drugs for March 2026

A weekly snapshot of newly reported, active covered outpatient drugs submitted by manufacturers to the Medicaid Drug Rebate Program from March 2 to March 8, 2026. The data is provided by the U.S. Department of Health & Human Services and captures updates made since the last quarterly database refresh.

Use Cases

• Identify newly reported active covered outpatient drugs for market entry analysis.
• Track manufacturer submissions to the Medicaid Drug Rebate Program for compliance monitoring.
• Analyze weekly updates to the MDRP database for drug coverage and rebate program research.

Strengths

• Data is sourced from the authoritative U.S. Department of Health & Human Services.
• Provides a specific weekly time range from March 2 to March 8, 2026.
• Focuses on newly reported drugs, offering timely updates to the quarterly MDRP database.

Limitations

• No column definitions or sample data are provided, limiting understanding of the data structure.
• The row count and dataset size are unknown, preventing assessment of its scale.
• The data is a weekly snapshot, lacking historical context for longitudinal analysis.

Provenance

Source

U.S. Department of Health & Human Services

Collection Method

Reported by participating drug manufacturers to the Medicaid Drug Rebate Program.

Time Range

March 2, 2026 to March 8, 2026

Freshness

Updated on March 11, 2026, covering the prior week.

Geography

United States